Thereafter, Phillips et al. (2006) showed that the breast cancer cells expressing CD44+/CD24−/low are more radioresistant, supporting a notion that CSCs are more radioresistant than the non-stem cancer cells and placing CSC research at the core of tumor adaptive radioresistance studies. This evidence concerns the gene CD44 and breast cancer.